July 24, 2014 1:00 PM ET

Pharmaceuticals

Company Overview of Relevare Pharmaceuticals LTD.

Company Overview

Relevare Pharmaceuticals LTD., a specialty pharmaceutical company, develops therapies to treat chronic and acute pain in Australia. It develops CNSB015 and CNSB001, a fixed dose combination therapy for neuropathic pain; CNSB002, a sodium channel antagonist with antioxidant properties for the treatment of inflammatory and neuropathic pain; CNSB004, an N-type calcium channel antagonist for the treatment of severe pain; and CNSB006 and CNSB007, a therapy for inflammatory and neuropathic pain. Relevare Pharmaceuticals LTD. was formerly known as CNSBio Pty Ltd. and changed its name to Relevare Pharmaceuticals LTD. in April 2010. The company was founded in 2003 and is based in Abbotsford, Australi...

Suite 1

651 Victoria Street

Abbotsford, VIC 3067

Australia

Founded in 2003

Key Executives for Relevare Pharmaceuticals LTD.

Chief Executive Officer
Chief Financial Officer and Company Secretary
Chief Medical Officer
Age: 66
Compensation as of Fiscal Year 2014.

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Relevare Pharmaceuticals LTD., please visit www.relevarepharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.